Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical Testing

Abstract

ABSTRACT Several Etest (AB BIODISK, Solna, Sweden) gradient formats were developed for detection of metallo-β-lactamases based on the reduction of imipenem (IP) or ceftazidime (TZ) MICs in the presence of EDTA or 2-mercaptopropionic acid (MPA). The Etest metallo-β-lactamase (Etest MBL) strips consisted of a double-sided seven-dilution range of IP or TZ (4 to 256 μg/ml) and IP or TZ (1 to 64 μg/ml) overlaid with a constant concentration of EDTA or MPA. The prototype strips were evaluated on several agar media (brain heart infusion agar, Isosensitest agar, nutrient agar, and Mueller-Hinton agar for aerobes and brucella blood agar for anaerobes) with 138 challenge strains: Acinetobacter spp. ( n = 9), Aeromonas spp. ( n = 8), Chryseobacterium spp. ( n = 28), Escherichia coli ( n = 1), Klebsiella pneumoniae ( n = 4), Pseudomonas aeruginosa ( n = 14), Proteus mirabilis ( n = 3), Serratia spp. ( n = 10), Stenotrophomonas maltophilia ( n = 43), Sphingobacterium spp. ( n = 3), and Bacteroides fragilis group ( n = 15). PCR analysis using specific primers for IMP-1, L1, CcrA, and bla B/C confirmed the presence of the metallo-β-lactamase genes. Enzyme assays were also performed with IP as an indicator substrate followed by EDTA inhibition profiles. EDTA was found to be a better inhibitor of metallo-β-lactamases, especially for anaerobes. IP was a better than TZ. Mueller-Hinton agar was the preferred medium, particularly when compared to Isosensitest agar, which frequently produced falsely low MICs for IP. Etest IP plus IP-EDTA with Mueller-Hinton agar had a sensitivity of 94% (79 of 84) and specificity of 95% (124 of 130). The Etest MBL strip appears to be an acceptable diagnostic reagent to detect metallo-β-lactamase phenotypes in the clinical microbiology laboratory.